Unique features of apicoplast DNA gyrases from and

BMC Bioinformatics

Volumn 15, Issue 1, 2014, Pages

  Nagano, Soshichiro ^a   Lin, Ting Yu ^a   Edula, Jyotheeswara Reddy ^a,b   Heddle, Jonathan Gardiner ^a  

^a RIKEN   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Apicoplast; DNA gyrase; malaria toxoplasmosis; Negative supercoiling; Topoisomerase

Indexed keywords

DNA; ENZYMES; PLANTS (BOTANY); PROTOZOA;

APICOPLAST; DNA GYRASES; MALARIA TOXOPLASMOSIS; NEGATIVE SUPERCOILING; TOPOISOMERASES;

PROTEINS;

APICOMPLEXA; BACTERIA (MICROORGANISMS); EUKARYOTA;

BACTERIAL PROTEIN; BRACHYURY PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FETOPROTEIN; T BOX TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; APICOPLAST; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; ENZYMOLOGY; GENETICS; HUMAN; MALARIA FALCIPARUM; METABOLISM; MOLECULAR GENETICS; PARASITOLOGY; PLASMODIUM FALCIPARUM; SEQUENCE HOMOLOGY; TOXOPLASMA; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; APICOPLASTS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; COMPUTER SIMULATION; DNA GYRASE; FETAL PROTEINS; HUMANS; MALARIA, FALCIPARUM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; SEQUENCE HOMOLOGY, AMINO ACID; T-BOX DOMAIN PROTEINS; TOXOPLASMA;

EID: 84924059002     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-014-0416-9     Document Type: Article

References (72)

1. Lim L, McFadden GI: The evolution, metabolism and functions of the apicoplast. Phil Trans R Soc B 2010, 365(1541):749-763.
2. van Dooren GG, Striepen B: The algal past and parasite present of the apicoplast. Annu Rev Microbiol 2013, 67(1):null.
3. WHO: World Malaria Report. Geneva: World Health Organization Press; 2012.
4. Centers for Disease Control and Prevention [ http://www.cdc.gov/parasites/npi.html ]
5. Petersen I, Eastman R, Lanzer M: Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett 2011, 585(11):1551-1562.
6. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. New Engl J Med 2009, 361(5):455-467.
7. Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NP, White NJ, Dondorp AM: High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis 2010, 201(9):1326-1330.
8. The RTS, S Clinical Trials Partnership.: A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. New Engl J Med 2012, 367(24):2284-2295.
9. Seder RA, Chang L-J, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li ML, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJM, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, et al: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013. 341:1359-1365
10. Sims PG: Drug Resistance in Toxoplasma gondii. In: Antimicrobial Drug Resistance. Edited by Mayers D: Humana Press; New York: 2009: 1121-1126.
11. Fichera ME, Roos DS: A plastid organelle as a drug target in apicomplexan parasites. Nature 1997, 390(6658):407-409.
12. He CY, Shaw MK, Pletcher CH, Striepen B, Tilney LG, Roos DS: A plastid segregation defect in the protozoan parasite Toxoplasma gondii. Embo J 2001, 20(3):330-339.
13. Yeh E, DeRisi JL: Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum . PLoS Biol 2011, 9(8):e1001138.
14. Pradel G, Schlitzer M: Antibiotics in malaria therapy and their effect on the parasite apicoplast. Curr Mol Med 2010, 10(3):335-349.
15. Collin F, Karkare S, Maxwell A: Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol 2011, 92(3):479-497.
16. Nöllmann M, Crisona NJ, Arimondo PB: Thirty years of escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism. Biochimie 2007, 89(4):490-499.
17. Corbett KD, Shultzaberger RK, Berger JM: The C-terminal domain of DNA gyrase A adopts a DNA-bending ß-pinwheel fold. Proc Natl Acad Sci U S A 2004, 101(19):7293-7298.
18. Chaudhuri I, Soding J, Lupas AN: Evolution of the beta-propeller fold. Proteins 2008, 71(2):795-803.
19. Aravind L, Leipe DD, Koonin EV: Toprim - a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins. Nucl Acids Res 1998, 26(18):4205-4213.
20. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD: The Pfam protein families database. Nucl Acids Res 2012, 40(Database issue):D290-D301.
21. Geourjon C, Deleage G: SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 1995, 11(6):681-684.
22. Schoeffler AJ, Berger JM: Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism. Biochem Soc Trans 2005, 33(Pt 6):1465-1470.
23. Wall MK, Mitchenall LA, Maxwell A: Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria. Proc Natl Acad Sci USA 2004, 101(20):7821-7826.
24. Divo AA, Sartorelli AC, Patton CL, Bia FJ: Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 1988, 32(8):1182-1186.
25. Weissig V, Vetro-Widenhouse TS, Rowe TC: Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum. DNA Cell Biol 1997, 16(12):1483-1492.
26. Krishna S, Davis TM, Chan PC, Wells RA, Robson KJ: Ciprofloxacin and malaria. Lancet 1988, 1(8596):1231-1232.
27. Khan AA, Slifer T, Araujo FG, Remington JS: Trovafloxacin is active against Toxoplasma gondii. Antimicrob Agents Chemother 1996, 40(8):1855-1859.
28. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, et al: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419(6906):498-511.
29. García-Estrada C, Prada CF, Fernández-Rubio C: Rojo-Vázquez F, Balaña-Fouce R: DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. P Roy Soc B-Biol Sci 2010, 277(1689):1777-1787.
30. Gozalbes R, Brun-Pascaud M, Garcia-Domenech R, Galvez J, Girard PM, Doucet JP, Derouin F: Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques. Antimicrob Agents Chemother 2000, 44(10):2771-2776.
31. Mahmoudi N, Ciceron L, Franetich JF, Farhati K, Silvie O, Eling W, Sauerwein R, Danis M, Mazier D, Derouin F: In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother 2003, 47(8):2636-2639.
32. Piddock LJ, Zhu M: Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria. Antimicrob Agents Chemother 1991, 35(11):2423-2427.
33. Goodman CD, Su V, McFadden GI: The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 2007, 152(2):181-191.
34. Raghu Ram EV, Kumar A, Biswas S, Chaubey S, Siddiqi MI, Habib S: Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication. Mol Biochem Parasitol 2007, 154(1):30-39.
35. Dar MA, Sharma A, Mondal N, Dhar SK: Molecular cloning of apicoplast-targeted plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit. Eukaryot Cell 2007, 6(3):398-412.
36. Ali JA, Jackson AP, Howells AJ, Maxwell A: The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 1993, 32(10):2717-2724.
37. Dar A, Prusty D, Mondal N, Dhar SK: A unique 45-amino-acid region in the toprim domain of plasmodium falciparum gyrase B is essential for its activity. Eukaryot Cell 2009, 8(11):1759-1769.
38. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S: MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013, 30(12):2725-2729.
39. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG: Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23(21):2947-2948.
40. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994, 22(22):4673-4680.
41. Ruthenburg AJ, Graybosch DM, Huetsch JC, Verdine GL: A superhelical spiral in the Escherichia coli DNA gyrase A C-terminal domain imparts unidirectional supercoiling bias. J Biol Chem 2005, 280(28):26177-26184.
42. Corbett KD, Schoeffler AJ, Thomsen ND, Berger JM: The structural basis for substrate specificity in DNA topoisomerase IV. J Mol Biol 2005, 351(3):545-561.
43. Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC: Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997, 388(6645):903-906.
44. Kramlinger VM, Hiasa H: The "GyrA-box" is required for the ability of DNA gyrase to wrap DNA and catalyze the supercoiling reaction. J Biol Chem 2006, 281(6):3738-3742.
45. Ward D, Newton A: Requirement of topoisomerase IV parC and parE genes for cell cycle progression and developmental regulation in Caulobacter crescentus. Mol Microbiol 1997, 26(5):897-910.
46. Hsieh TJ, Yen TJ, Lin TS, Chang HT, Huang SY, Hsu CH, Farh L, Chan NL: Twisting of the DNA-binding surface by a beta-strand-bearing proline modulates DNA gyrase activity. Nucleic Acids Res 2010, 38(12):4173-4181.
47. Hsieh TJ, Farh L, Huang WM, Chan NL: Structure of the topoisomerase IV C-terminal domain: a broken beta-propeller implies a role as geometry facilitator in catalysis. J Biol Chem 2004, 279(53):55587-55593.
48. Tretter EM, Berger JM: Mechanisms for defining supercoiling Set point of DNA gyrase orthologs: II. The shape of the GyrA subunit C-terminal domain (Ctd) is Not a sole determinant for controlling supercoiling efficiency. J Biol Chem 2012, 287(22):18645-18654.
49. Holdgate GA, Tunnicliffe A, Ward WH, Weston SA, Rosenbrock G, Barth PT, Taylor IW, Pauptit RA, Timms D: The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study. Biochemistry 1997, 36(32):9663-9673.
50. Aravind L, Iyer LM, Wellems TE, Miller LH: Plasmodium biology: genomic gleanings. Cell 2003, 115(7):771-785.
51. Muralidharan V, Goldberg DE: Asparagine repeats in plasmodium falciparum proteins: good for nothing? PLoS Pathog 2013, 9(8):e1003488.
52. Verra F, Hughes AL: Biased amino acid composition in repeat regions of Plasmodium antigens. Mol Biol Evol 1999, 16(5):627-633.
53. Hughes AL: The evolution of amino acid repeat arrays in Plasmodium and other organisms. J Mol Evol 2004, 59(4):528-535.
54. Dutta R, Inouye M: GHKL, an emergent ATPase/kinase superfamily. Trends Biochem Sci 2000, 25(1):24-28.
55. Waller RF, Keeling PJ, Donald RG, Striepen B, Handman E, Lang-Unnasch N, Cowman AF, Besra GS, Roos DS, McFadden GI: Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci U S A 1998, 95(21):12352-12357.
56. Parsons M, Karnataki A, Feagin JE, DeRocher A: Protein trafficking to the apicoplast: deciphering the apicomplexan solution to secondary endosymbiosis. Eukaryot Cell 2007, 6(7):1081-1088.
57. Ralph SA, Foth BJ, Hall N, McFadden GI: Evolutionary pressures on apicoplast transit peptides. Mol Biol Evol 2004, 21(12):2183-2194.
58. Cilingir G, Broschat SL, Lau AO: ApicoAP: the first computational model for identifying apicoplast-targeted proteins in multiple species of Apicomplexa. PLOS ONE 2012, 7(5):e36598.
59. Gasteiger E, Hoogland C, Gattiker A, Duvaud Se, Wilkins M, Appel R, Bairoch A: Protein Identification and Analysis Tools on the ExPASy Server. In: The Proteomics Protocols Handbook. Edited by Walker J: Humana Press; New York: 2005: 571-607.
60. Foth BJ, Ralph SA, Tonkin CJ, Struck NS, Fraunholz M, Roos DS, Cowman AF, McFadden GI: Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science 2003, 299(5607):705-708.
61. Zhang Y: I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008, 9(1):40.
62. Roy A, Kucukural A, Zhang Y: I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protocols 2010, 5(4):725-738.
63. Laponogov I, Veselkov DA, Crevel IM-T, Pan X-S, Fisher LM, Sanderson MR: Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport. Nucl Acids Res 2013, 41(21):9911-9923.
64. Khor V, Yowell C, Dame JB, Rowe TC: Expression and characterization of the ATP-binding domain of a malarial Plasmodium vivax gene homologous to the B-subunit of the bacterial topoisomerase DNA gyrase. Mol Biochem Parasitol 2005, 140(1):107-117.
65. Ostrov DA, Hernandez Prada JA, Corsino PE, Finton KA, Le N, Rowe TC: Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother 2007, 51(10):3688-3698.
66. Yoshida H, Bogaki M, Nakamura M, Nakamura S: Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990, 34(6):1271-1272.
67. Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S: Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother 1991, 35(8):1647-1650.
68. Aubry A, Fisher LM, Jarlier V, Cambau E: First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis. Biochem Biophys Res Comm 2006, 348(1):158-165.
69. Manjunatha UH, Dalal M, Chatterji M, Radha DR, Visweswariah SS, Nagaraja V: Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase. Nucleic Acids Res 2002, 30(10):2144-2153.
70. Karkare S, Yousafzai F, Mitchenall LA, Maxwell A: The role of Ca2+ in the activity of Mycobacterium tuberculosis DNA gyrase. Nucleic Acids Res 2012, 40(19):9774-9787.
71. Schrodinger, LLC: The PyMOL Molecular Graphics System, Version 1.3r1. In.; 2010.
72. Emsley P, Lohkamp B, Scott WG, Cowtan K: Features and development of Coot. Acta Crystallogr D 2010, 66(Pt 4):486-501.